Flux Robotics
Flux Robotics' Flux 2 robot revolutionizes vascular stent implantation, cutting procedure time from 3 hours to 45 minutes, reducing radiation exposure, and saving up to $20K per patient. After successful animal trials, we seek $1.3M for pre-clinical trials, clinical team expansion, and US market entry. Join us!
Achievement
- Successfull MVP built - Successfull animal trials Phase 1, showcasing feasibility and safety of our guidewires in a live pig - 4 KOLs on board to support us and advise us - 3 key advisors from Silicon Valley - Health-economic model validated and also a compelte reimbursement plan - FDA Q-submission started
Overijssel
Industry
Hardware, Health, MedTech
SDGs
Good health and well-being (SDG #3), Gender equality (SDG #5), Partnerships for the goals (SDG #17), Decent work and economic growth (SDG #8)
Patent information
Yes, a patent pending for our core technology and we plan to file more patents on our disposable tech in Q3 2025.